OXY GENE

Serial Number 79280862
Registration 6557311
700

Registration Progress

Application Filed
Jan 15, 2020
Under Examination
Approved for Publication
Aug 31, 2021
Published for Opposition
Aug 31, 2021
Registered
Nov 16, 2021

Trademark Image

OXY GENE

Basic Information

Serial Number
79280862
Registration Number
6557311
Filing Date
January 15, 2020
Registration Date
November 16, 2021
Published for Opposition
August 31, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 16, 2021
Registration
Registered
Classes
042

Rights Holder

HENOGEN

99
Address
Rue Des Professeurs Jeener et Brachet 12
B-6041 Gosselies
BE

Ownership History

NOVASEP PROCESS

Original Applicant
99
F-54340 POMPEY FR

HENOGEN

New Owner Before Publication #1
99
B-6041 Gosselies BE

HENOGEN

Owner at Publication
99
B-6041 Gosselies BE

HENOGEN

Original Registrant
99
B-6041 Gosselies BE

Legal Representation

Attorney
Monte L. Falcoff/Jessica S. Sachs

USPTO Deadlines

Next Deadline
699 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20211116)
Due Date
November 16, 2027
Grace Period Ends
May 16, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
May 4, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 23, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 3, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 3, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 16, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 16, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 31, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 31, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 29, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Aug 23, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 11, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 11, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Aug 11, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 25, 2021 EXPT T EXPARTE APPEAL TERMINATED Loading...
Jul 23, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 23, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 23, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 23, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 23, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 13, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 13, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 9, 2021 ALIE A ASSIGNED TO LIE Loading...
May 25, 2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
May 10, 2021 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Apr 9, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 6, 2021 CORN I CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Apr 3, 2021 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Mar 5, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 26, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jan 26, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jan 26, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jan 19, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 19, 2021 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Jan 19, 2021 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Jan 19, 2021 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Oct 26, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 26, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 26, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 20, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 20, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 20, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 14, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 14, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 14, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 15, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 28, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 28, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 11, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 10, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 1, 2020 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 042
Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents

Additional Information

Design Mark
The mark consists of the stylized wording "OXY". The "O" and "X" are in blue, and the "Y" is in blue and purple. Below this wording is the stylized wording "GENE". The "G" is in blue and purple, the "E" is in blue, purple, and orange, and the "N" and "E" are in orange. There is a stylized blue, purple, red, and orange incomplete, wavy circle to the left of the wording that extends towards the right. The color white represents background and is not claimed as a part of the mark.
Color Claim
The color(s) purple, blue, orange, and red is/are claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE"